Holen Sie sich die Stockscreener-App
2.08
103.92%
1.06
Vorhandelsmarkt:
1.65
-0.43
-20.67%
Schlusskurs vom Vortag:
$1.02
Offen:
$1.29
24-Stunden-Volumen:
115.16M
Relative Volume:
43.15
Marktkapitalisierung:
$23.40M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-3.10M
KGV:
-0.1271
EPS:
-16.3657
Netto-Cashflow:
$-1.93M
1W Leistung:
+22.35%
1M Leistung:
-20.91%
6M Leistung:
-61.02%
1J Leistung:
-75.47%
1-Tages-Spanne:
$1.1801
$3.22
1-Wochen-Bereich:
$0.97
$3.22
52-Wochen-Spanne:
$0.97
$11.92
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Vergleichen Sie SXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.08 | 23.40M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
149.99 | 66.56B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.33 | 45.76B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.45 | 45.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
14.00 | 16.04B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.82 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
China Sxt Pharmaceuticals Inc Aktie (SXTC) Neueste Nachrichten
Promising Chinese Stocks To Keep An Eye OnApril 20th - MarketBeat
3 Penny Stocks to Watch Now, 4/22/25 - TipRanks
Promising Chinese Stocks To Keep An Eye On – April 20th - Defense World
China SXT Pharmaceuticals Inc [SXTC] is -46.86% lower this YTD. Is it still time to buy? - dbtnews.com
Top Chinese Stocks To Research – April 19th - Defense World
Pre-market Movers In Healthcare Sector: CTXR, VCNX, SRNE, ITRM, RWLK… - RTTNews
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges - TipRanks
China SXT Pharmaceuticals regains compliance with Nasdaq’s minimum bid price deficiency - MSN
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks
China SXT Pharmaceuticals Regains Compliance With Nasdaq's Minimum Bid Price Requirement - Nasdaq
China SXT Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - Nasdaq
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency - GlobeNewswire
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 1,448.9% in February - Defense World
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Stock market news: China SXT Pharmaceuticals plummented by 92.58% while Wah Fu Education Group skyrocketed by 78.37% during midday trading - Business Upturn
Stock market today: China SXT Pharmaceuticals -93.05%, Comstock -90.24% among biggest losers in early trading - Business Upturn
Stock market today: China SXT Pharmaceuticals plunged by 92.61% while Wah Fu Education Group surged by 239.75% in early trading - Business Upturn
SXTC stock touches 52-week high of $3.95 amid market fluctuations - Investing.com India
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
China SXT Pharmaceuticals announces 1-for-8 share consolidation - Investing.com
China SXT Pharmaceutics, Inc. Announces 1-for-8 Share Consolidation to Regain Nasdaq Compliance - Nasdaq
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire
Will SXTC's Share Consolidation Save Its Nasdaq Listing? Key Dates Revealed - StockTitan
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China SXT Pharmaceuticals, Inc. Announces CEO Changes -January 23, 2025 at 04:15 pm EST - Marketscreener.com
Pre-market Movers: CDT, NARI, GDTC, NARI... - RTTNews
Before Buying China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock, Read This First - Stocks Register
China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy? - Defense World
SXTC stock hits 52-week low at $0.36 amid sharp annual decline - Investing.com
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Inkl
SXTC stock hits 52-week low at $0.37 amid sharp annual decline - Investing.com Australia
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
China SXT Pharmaceuticals: Operational Risks and Profit Repatriation Challenges - TipRanks
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - markets.businessinsider.com
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule - Yahoo Finance
China SXT Pharma (NASDAQ: SXTC) to jump 2,500%a purely technical move - Dhaka Tribune
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewswire
Finanzdaten der China Sxt Pharmaceuticals Inc-Aktie (SXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.83%
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):